investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Defining the role of eIF4F in metastatic castration resistant prostate cancer
Andrew Caleb Hsieh
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Andrew Caleb Hsieh
Fred Hutchinson Cancer Research Center
Seattle, United States
Related projects
Serigne Magueye
Ethnic Difference in Prostate Cancer
Prostate
Pathology
Hans Lilja
Prospective validation of a multi-marker prostate cancer prediction model
Prostate
Joshi J Alumkal
The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer
Prostate
Pathology
Allen C Gao
Interleukin-6 and Castration-Resistant Prostate Cancer
Prostate
Pathology
Dario C Altieri
Control of Apoptosis in Cancer by Survivin
Prostate
Pathology
Clare M Tempany
Enabling Technologies For MRI-Guided Prostate Interventions
Prostate
Pathology
Massimo Loda
Molecular Link Between Metabolic Syndrome and Prostate Cancer
Prostate
Yan Xu
Role of immune cell OGR1 in prostate cancer development and the mechanisms involv
Prostate
Pathology
Charles L. Sawyers
Understanding Resistance to Next Generation Antiandrogens
Prostate